Lisa Gill
Stock Analyst at JP Morgan
(3.27)
# 948
Out of 4,884 analysts
137
Total ratings
48.31%
Success rate
1.94%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $405 → $418 | $308.55 | +35.47% | 8 | Jun 20, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $22.11 | +44.73% | 5 | May 28, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $176.92 | +7.39% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $20.56 | +45.91% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $31.16 | +31.58% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $13.57 | +25.28% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $239.68 | +6.81% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $67.43 | +20.12% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $164.93 | -12.08% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $296.23 | +1.61% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $13.14 | +36.99% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $4.46 | +12.11% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $22.15 | +26.41% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.47 | +30.78% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $8.29 | +8.56% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $9.21 | +95.44% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $719.30 | -8.11% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $319.75 | +36.98% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.39 | +34.43% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $239.58 | +64.87% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $261.89 | -7.21% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $184.53 | +0.80% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $171.50 | -18.37% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $376.58 | -11.84% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $347.84 | +81.41% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.71 | +112.31% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $2.43 | +270.37% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.65 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $4.79 | +67.01% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $74.67 | +11.16% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $33.31 | +194.21% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.01 | - | 4 | Dec 19, 2017 |
UnitedHealth Group
Jun 20, 2025
Maintains: Overweight
Price Target: $405 → $418
Current: $308.55
Upside: +35.47%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $22.11
Upside: +44.73%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $176.92
Upside: +7.39%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $20.56
Upside: +45.91%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.16
Upside: +31.58%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $13.57
Upside: +25.28%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $239.68
Upside: +6.81%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $67.43
Upside: +20.12%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $164.93
Upside: -12.08%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $296.23
Upside: +1.61%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $13.14
Upside: +36.99%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $4.46
Upside: +12.11%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $22.15
Upside: +26.41%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.47
Upside: +30.78%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $8.29
Upside: +8.56%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $9.21
Upside: +95.44%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $719.30
Upside: -8.11%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $319.75
Upside: +36.98%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.39
Upside: +34.43%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $239.58
Upside: +64.87%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $261.89
Upside: -7.21%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $184.53
Upside: +0.80%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $171.50
Upside: -18.37%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $376.58
Upside: -11.84%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $347.84
Upside: +81.41%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.71
Upside: +112.31%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $2.43
Upside: +270.37%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.65
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $4.79
Upside: +67.01%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $74.67
Upside: +11.16%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $33.31
Upside: +194.21%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $22.01
Upside: -